Chromogenicin situhybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenicin situhybridization with immunohistochemistry and fluorescencein situhybridization-Reference-Cited by-同舟云学术

Chromogenicin situhybridization for Her-2/neu-oncogene in breast cancer: comparison of a new dual-colour chromogenicin situhybridization with immunohistochemistry and fluorescencein situhybridization

Published:2009-12 Issue:6 Volume:55 Page:716-723
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Mayr Doris,Heim Sibylle,Weyrauch Kerstin,Zeindl-Eberhart Evelyn,Kunz Anne,Engel Jutta,Kirchner Thomas

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2009.03427.x/fullpdf

Reference24 articles.

1. Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?;Sauer;Apmis,2003

2. Low HER2/neu gene expression is associated with pathological response to concurrent paclitaxel and radiation therapy in locally advanced breast cancer;Formenti;Int. J. Radiat. Oncol. Biol. Phys.,2002

3. Therapy of breast cancer with molecular targeting agents;Gasparini;Ann. Oncol.,2005

4. Prognostic importance of c-erbB-2 expression in breast cancer. International (Ludwig) Breast Cancer Study Group;Gusterson;J. Clin. Oncol.,1992

5. HER-2/neu as a predictive marker of response to breast cancer therapy;Pegram;Breast Cancer Res. Treat.,1998

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Predictive Biomarkers in Breast Cancer: ER, PR, and HER-2/NEU;Handbook of Practical Immunohistochemistry;2022

2. The basics of immunohistochemistry;In Situ Molecular Pathology and Co-Expression Analyses;2021

3. The basics of in situ hybridization;In Situ Molecular Pathology and Co-Expression Analyses;2021

4. The biochemical basis of in situ hybridization and immunohistochemistry;In Situ Molecular Pathology and Co-Expression Analyses;2021

5. Practical application of non-contact alternating current electric field mixing for reagent-saving in situ hybridisation of HER2;Journal of Clinical Pathology;2019-05-25